Congenital malformations due to antiepileptic drugs
Introduction
Improved diagnosis and therapy of epilepsy has allowed most women with epilepsy to marry and bear children. However, the incidence of congenital malformations in offspring of mothers with epilepsy who were treated with antiepileptic drugs (AEDs) during pregnancy is higher than the normal population (Dansky et al., 1982, Nakane, 1982) and higher than in offspring whose mothers were not treated with AEDs during pregnancy (Koch et al., 1982, Lindhout et al., 1982, Kaneko et al., 1986).
In recent prospective studies, teratogenicity appeared to be attributable to AEDs rather than to epilepsy (Kaneko et al., 1986, Kaneko et al., 1992). Folate deficiency in response to AED therapy (Ogawa et al., 1991, Dansky et al., 1992) and genetically determined drug detoxifying enzyme activity have been related to the occurrence of malformations (Buehler et al., 1990). The involvement of other risk factors, however, such as maternal hypoxia, and genetic influences, must also be considered in the etiology of congenital malformations. The aim of the present study was to identify the major risk factors for the occurrence of congenital malformations, the relative teratogenic risk of each AED, and the advisable ranges of AED doses to reduce the risk of congenital malformations in offspring.
Section snippets
Subjects and methods
For this prospective study, the same study design was used to collect and analyze the same data from three countries (Japan (Hirosaki, Fukushima, Nagoya, and Nagasaki), Italy (Milan), and Canada (Montreal)). This study was approved by the Ethics Committee in each center.
Recruitment of subjects began in April 1978, and was completed in December 1991. At each center, where the study was introduced, the nature and purpose of the study was explained to every female patient of childbearing age with
Statistics
For statistical analysis, first we estimated the incidence of malformations in the total group and in each subgroup. Next, we examined the correlation between the occurrence of malformations and the following factors: (a) background factors of the mothers, (b) AED combination profiles, (c) the number of AEDs administered, and (d) AED doses and levels.
We used the following tests for each data group: exact probability method, chi-square test, Wilcoxon rank sum test and Welch's test in evaluating
Results
Among 983 pregnancies, 83 malformed infants were observed (8.4%). The overall incidence of malformations in AED exposed offspring was 9.0% (80/885). Three anomalies such as a flexion of the thumb, distorted fingers, and a small nevus were observed in AED unexposed offspring. None of the mothers had any associated chronic illness.
Discussion
Reported risk factors for congenital malformations in offspring vary from report to report (Dansky et al., 1982Koch et al., 1982Lindhout et al., 1982Nakane, 1982Kaneko et al., 1986Kaneko et al., 1992). This is due mainly to the small number of subjects in each study which inevitably results in insufficient statistical power. Thus, this study was designed to collect many cases from epilepsy centers where collaborative study and precise follow-ups were possible.
A significantly higher incidence of
Acknowledgements
This study was supported by a Grant in Aid for Scientific Research from the Japanese Ministry of Education, Science and Culture (05454309) and a grant from the Japan Epilepsy Research Foundation. Part of the present study was reported at the 19th CINP congress held in Washington DC, USA, in June 1994, and the 21st International Epilepsy Congress held in Sydney, Australia in September 1995. A preliminary report (in Japanese) of this study was reported in the Annual Report of the Japanese
References (41)
- et al.
Is the epileptic genotype teratogenic?
Lancet
(1978) - et al.
Minor anomalies in offspring of epileptic mothers
J. Pediatr.
(1988) - et al.
Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid
J. Pediatr.
(1986) Antiepileptic drug therapy and reproductive consequences: functional and morphologic effects
Reprod. Toxicol.
(1991)- et al.
In-utero exposure to valproate and neural tube defects
Lancet
(1986) - et al.
Serum folic acid levels in epileptic mothers and their relationship to congenital malformations
Epilepsy Res.
(1991) - et al.
Valproate and birth defects
Lancet
(1983) - Annegers, J.F., Hauser, W.A., 1982. The frequency of congenital malformations in relatives of patients with epilepsy....
- et al.
Malformations in offspring of 305 epileptic women: a prospective study
Acta Neurol. Scand.
(1992) - et al.
Prenatal prediction of risk of the fetal hydantoin syndrome
N. Engl. J. Med.
(1990)
Mechanisms of teratogenesis: folic acid and antiepileptic therapy
Neurology
Protection from phenytoin-induced congenital malformations by coadministration of the antiepileptic drug stripentol in a mouse model
Epilepsia
Monitoring system of congenital malformation
J. Perinat. Med.
Maternal drug histories and congenital abnormalities
Br. Med. J.
Clinical application of therapeutic drug monitoring of antiepileptic drugs (in Japanese)
Clin. Pathol.
Teratogenicity of antiepileptic drugs—a prospective study
Jpn. J. Psychiatry Neurol.
Teratogenicity of antiepileptic drugs: analysis of possible risk factors
Epilepsia
Cited by (352)
Achieving neurologically desirable outcomes to pregnancy in women with epilepsy
2022, Epilepsy and BehaviorCerebral cavernous malformation: Management and outcome during pregnancy and puerperium. A systematic review of literature
2021, Journal of Gynecology Obstetrics and Human ReproductionGenotoxicity assessment of antiepileptic drugs (AEDs) in human embryonic stem cells
2019, Epilepsy ResearchTeratogenic potential of third-generation antiepileptic drugs: Current status and research needs
2019, Pharmacological ReportsPrevalence of valproate syndrome in Europe from 2005 to 2014: A registry based multi-centre study
2018, European Journal of Medical GeneticsPassive Addiction and Teratogenic Effects
2018, Volpe's Neurology of the Newborn